Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies
Cancer · 2025
DOI: 10.1002/cncr.35897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Yonghyo Kim und 29 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Melanoma, Proteome, Mitochondria, Skin Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Fru Berta Kamprads Stiftelse, Crafoordska Stiftelsen.
Abstract (Originalsprache)
Background
Melanoma, the deadliest form of skin cancer, exhibits resistance to conventional therapies, particularly in advanced and metastatic stages. Mitochondrial pathways, including oxidative phosphorylation and mitochondrial translation, have emerged as critical drivers of melanoma progression and therapy resistance. This study investigates the mitochondrial proteome in melanoma to uncover novel therapeutic vulnerabilities.
Methods
Quantitative proteomics was performed on 151 melanoma‐related samples from a prospective cohort and postmortem tissues. Differential expression analysis identified mitochondrial proteins linked to disease aggression and treatment resistance. Functional enrichment analyses and in vitro validation using mitochondrial inhibitors were conducted to evaluate therapeutic potential.
Results
Mitochondrial translation and oxidative phosphorylation (OXPHOS) were significantly upregulated in aggressive melanomas, particularly in BRAF‐mutant and metastatic tumors. Inhibition of mitochondrial pathways using antibiotics (doxycycline, tigecycline, and azithromycin) and OXPHOS inhibitors (VLX600, IACS‐010759, and BAY 87‐2243) demonstrated dose‐dependent antiproliferative effects in melanoma cell lines, sparing noncancerous melanocytes. These treatments disrupted mitochondrial function, suppressed key metabolic pathways, and induced apoptosis, highlighting the clinical relevance of targeting these pathways.
Conclusions
This study reveals mitochondrial pathways as critical drivers of melanoma progression and resistance, providing a rationale for targeting mitochondrial translation and OXPHOS in advanced melanoma. Combining mitochondrial inhibitors with existing therapies could overcome treatment resistance and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
- Therapeutics and Biotechnology Division, Data Convergence Drug Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Korea.
- Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
- Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.
- Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.
- Department of Biomedical Engineering, Clinical Protein Science & Imaging, Lund University, Lund, Sweden.
ORCID-Profile: Roger Appelqvist, Jeovanis Gil
Förderung
- National Research Foundation of Korea
- Fru Berta Kamprads Stiftelse
- Crafoordska Stiftelsen
Zitieren
APA
Kim, Y., Doma, V., Çakır, U., Kuras, M., Betancourt, L. H., Pla, I., Sanchez, A., Sugihara, Y., Appelqvist, R., Oskolas, H., Lee, B., Guedes, J., Monnerat, G., Carneiro, G. R. A., Nogueira, F. C. S., Domont, G. B., Malm, J., Baldetorp, B., Wieslander, E., …, & Gil, J. (2025). Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies. Cancer. https://doi.org/10.1002/cncr.35897
Vancouver
Kim Y, Doma V, Çakır U, Kuras M, Betancourt LH, Pla I, et al. Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies. Cancer. 2025. doi:10.1002/cncr.35897
BibTeX
@article{Kim2025,
author = {Kim, Yonghyo and Doma, Viktória and Çakır, Uğur and Kuras, Magdalena and Betancourt, Lazaro Hiram and Pla, Indira and Sanchez, Aniel and Sugihara, Yutaka and Appelqvist, Roger and Oskolas, Henriett and Lee, Boram and Guedes, Jéssica and Monnerat, Gustavo and Carneiro, Gabriel Reis Alves and Nogueira, Fábio C S and Domont, Gilberto B and Malm, Johan and Baldetorp, Bo and Wieslander, Elisabet and Németh, István Balázs and Szász, A Marcell and Hong, Runyu and Pawłowski, Krzysztof and Rezeli, Melinda and Kwon, Ho Jeong and Timar, Jozsef and Fenyö, David and Kárpáti, Sarolta and Marko-Varga, György and Gil, Jeovanis},
title = {Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35897}
}
EUVIMED